Jefferies analyst Michael Yee initiated coverage of Blueprint Medicines (BPMC) with a Buy rating and $135 price target The firm finds the stock “quite attractive,” especially on the recent ...

Scotiabank initiated coverage of Blueprint Medicines (BPMC) with an Outperform rating and $150 price target Stock performance has been “choppy,” but greater appreciation of the company’s $4B ...

The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is for research purposes. The European Medicines Agency (EMA) has added an ...

Dearest gentle reader, someone call a doctor because Married to Medicine Season 11 ended with a shocking (but grandiose) finale. Ahead of the three-part reunion, find out where the doctors and ...

Any messaging suggesting that vitamin A, including cod liver oil, could be an alternative to vaccination is “misleading,” said Dr. David Higgins, a pediatrician and preventive medicine ...

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. European venture capital firm Sofinnova Partners ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.

Company Logo Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report ...

Medicines may be processed, packaged, sold, and resold multiple times before reaching consumers. For regulators, it can be difficult to ensure the safety of drugs before they hit pharmacy shelves.